In breast cancer, circMTO1 (hsa-circ-007874) interacts with TNF Receptor Associated Factor 4 (TRAF4), consequently inhibiting the mitotic kinesin Eg5 protein level and reversing monastrol resistance [151]. Here, TRAF4 is linked to breast carcinoma.